Video Experimental Relacionado
Updated: Sep 10, 2025
07:14
A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
9.4K
MyPath Pain Pathway: desarrollo de una vía digital de atención centrada en el paciente para el dolor por cáncer
Morena Shkodra1, Amaia Urrizola1, Marie Fallon2
1European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Journal of pain and symptom management
|August 23, 2025
Resumen
Este estudio desarrolló una herramienta digital de evaluación del dolor para pacientes con cáncer para estandarizar el manejo del dolor. El objetivo de MyPath Pain Care Pathway (PCP) es mejorar la atención al paciente a través de una evaluación sistemática de los síntomas y estrategias de tratamiento personalizadas.
Área de la Ciencia:
- En el campo de la oncología
- Tratamiento del dolor
- Salud digital
Sus antecedentes:
- El dolor del cáncer afecta a muchos pacientes, y una parte significativa experimenta un manejo inadecuado del dolor.
- La falta de una evaluación estandarizada del dolor obstaculiza tanto la investigación como la práctica clínica, lo que afecta la calidad de vida del paciente.
Objetivo del estudio:
- Describir el desarrollo del contenido clínico de MyPath Pain Care Pathway (PCP).
- Implementar un enfoque de atención centrada en el paciente (PCC, por sus siglas en inglés) para la evaluación y el tratamiento sistemáticos de los síntomas en pacientes con cáncer.
- Ofrecer un tratamiento estandarizado y multidimensional del dolor por cáncer basado en los resultados informados por el paciente (PRO) y la evaluación clínica.
Principales métodos:
- Un grupo directivo internacional y multidisciplinario desarrolló un método sistemático de evaluación y diagnóstico del dolor por cáncer.
- Utilizó directrices basadas en la evidencia para la evaluación y el manejo del dolor.
- Contenido clínico desarrollado basado en PRO y evaluación clínica.
Principales resultados:
- La evaluación del dolor MyPath PCP incorpora cinco componentes clave: etiología, ubicación, intensidad, brotes y tratamiento.
- Recopilación de datos a través de PRO digitalizados y consulta clínica dentro de la solución digital MyPath.
- La herramienta sugerirá estrategias individualizadas de manejo del dolor y se implementará en 2025.
Conclusiones:
- El MyPath PCP ofrece un enfoque digital y estandarizado para la evaluación del dolor.
- Su objetivo es mejorar la calidad del tratamiento del dolor por cáncer en diversos entornos clínicos.
- Se adaptará en función de los comentarios de los usuarios.
Palabras clave:
Dolor por cáncerlas vías de atenciónCuidados paliativosatención centrada en el pacientecuidados personalizadosMás Videos Relacionados
Videos de Conceptos Relacionados
01:27Nursing Ethical Principles II
1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
01:13Patient-centered Care
2.3K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.3K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:25Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K